Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 2, 2004, Pages 498-504

  Xiao, Chun Yang ^a   Chen, Min ^a   Zsengellér, Zsuzsanna ^a   Szabó, Csaba ^a,b  

^a INOTEK CORPORATION   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; INO 1001; ISOINDOLE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DIABETES MELLITUS; DNA DAMAGE; ENZYME INHIBITION; HEART CONTRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TISSUE INJURY;

ANIMALS; APOPTOSIS INDUCING FACTOR; CELL NUCLEUS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME ACTIVATION; FLAVOPROTEINS; INDOLES; MALE; MEMBRANE PROTEINS; MYOCARDIAL INFARCTION; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, WISTAR;

EID: 3342958962     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.066803     Document Type: Article

References (38)

1. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, and Kolb H (1999) Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin. Nat Med 5:314-319.
2. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS, Kroemer G, et al. (2002) Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 158:507-517.
3. Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, Graham SH, Carcillo JA, Szabó C, and Clark RS (2003a) Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress. J Biol Chem 278:18426-18433.
4. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengellér Z, Szabó C, and Brownlee M (2003b) Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Investig 112:1049-1057.
5. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, et al. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3:1089-1095.
6. Grupp IL, Jackson TM, Hake P, Grupp G, and Szabó C (1999) Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts. J Mol Cell Cardiol 31:297-303.
7. Haffner SJ and Cassells H (2003) Hyperglycemia as a cardiovascular risk factor. Am J Med 115:6S-11S.
8. Hurst RT and Lee RW (2003) Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 139:824-834.
9. Khan TA, Ruel M, Bianchi C, Voisine P, Komjati K, Szabó C, and Sellke FW (2003) Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass, J Am Coll Surg 197:270-277.
10. Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, and Bril A (2002) Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury. Diabetes 51:1507-1514.
11. Kim GT, Chun YS, Park JW, and Kim MS (2003) Role of apoptosis-inducing factor in myocardial cell death by ischemia-reperfusion. Biochem Biophys Res Commun 303:619-624.
12. Komjáti K, Mabley JG, Virág L, Southan GJ, Salzman AL, and Szabó C (2004) Poly(ADP-ribose) polymerase inhibition protects neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke. Int J Mol Med 13:373-382.
13. Liaudet L, Soriano FG, Szabó E, Virág L, Mabley JG, Salzman AL, and Szabó C (2000) Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase. Proc Natl Acad Sci USA 97:10203-10208.
14. Liaudet L, Szabó E, Timashpolsky L, Virág L, Cziraki A, and Szabó C (2001) Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br J Pharmacol 133:1424-1430.
15. Marfella R, Di Filippo C, Esposito K, Nappo F, Piegari E, Cuzzocrea S, Berrino L, Rossi F, Giugliano D, and D'Amico M (2004) Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 53:454-462.
16. Murakami K, Enkhbaatar P, Shimoda K, Cox RA, Burke AS, Hawkins HK, Traber LD, Schmalstieg FC, Salzman AL, Mabley JG, et al. (2004) Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis. Shock 21:126-133.
17. Murthy KGK, Xiao CY, Mabley JG, Chen M, and Szabó C (2004) Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction. Shock 21:230-234.
18. Obrosova IG, Li F, Abatan OI, Forsell MA, Komjáti K, Pacher P, Szabó C, and Stevens MJ (2004) Role of poly(ADP-ribose) polymerase in diabetic neuropathy. Diabetes 53:711-720.
19. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, and de Murcia G (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP- ribose) polymerase-1 deficient mice. EMBO (Eur Mol Biol Organ) J 18:4446-4454.
20. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabó E, and Szabó C (2002) The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51:514-521.
21. Pieper AA, Walles T, Wei G, Clements EE, Verma A, Snyder SH, and Zweier JL (2000) Myocardial postischemic injury is reduced by poly (ADP ribose) polymerase-1 I gene disruption. Mol Med 6:271-282.
22. Shimoda K, Murakami K, Enkhbaatar P, Traber LD, Cox RA, Hawkins HK, Schmalstieg FC, Komjati K, Mabley JG, Szabó C, et al. (2003) Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol 285:L240-L249.
23. Skaper SD (2003) Poly(ADP-ribosyl)ation enzyme-1 as a target for neuroprotection in acute central nervous system injury. Curr Drug Target CNS Neurol Disord 2:279-291.
24. Soriano FG, Virág L, Jagtap P, Szabó E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, et al. (2001) Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat Med 7:108-113.
25. Southan GJ and Szabó C (2003) Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 10:321-340.
26. Szabó C, editor (2000) Cell Death: The Role of PARP. CRC Press, Boca Raton, FL.
27. Szabó C, Cuzzocrea S, Zingarelli B, O'Connor M, and Salzman AL (1997) Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Investig 100:723-735.
28. Szabó C, Virág L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, Zingarelli B, Salzman A, and Kun E (1998) Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 95:3867-3872.
29. Szabó C, Zanchi A, Komjati K, Pacher P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, and Veves A (2002) Poly(ADP-ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 106:2680-2686.
30. Szabó G, Liaudet L, Hagl S, and Szabó C (2004) Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res 61:471-480.
31. Thiemermann C, Bowes J, Myint FP, and Vane JR (1997) Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 94:679-683.
32. Varbiro G, Toth A, Tapodi A, Bognar Z, Veres B, Sumegi B, and Gallyas F Jr (2003) Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. J Pharmacol Exp Ther 307:615-625.
33. Virág L, Salzman AL, and Szabó C (1998) Poly (ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 161:3753-3759.
34. Virág L and Szabó C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429.
35. Yang Z, Zingarelli B, and Szabó C (2000) Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock 13:60-66.
36. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, and Dawson VL (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science (Wash DC) 297:259-263.
37. Zingarelli B, Cuzzocrea S, Zsengellér Z, Salzman AL, and Szabó C (1997) Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 36:205-215.
38. Zingarelli B, Salzman AL, and Szabó C (1998) Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83:85-94.